126 related articles for article (PubMed ID: 36736464)
1. Involvement of CYP3A4 and MDR1 in altered metabolism and transport of indinavir in 1,25(OH)
Lee SJ; Joo SA; Kim H; Lee Y; Chung SJ; Chae YJ; Maeng HJ
Eur J Pharm Sci; 2023 Apr; 183():106396. PubMed ID: 36736464
[TBL] [Abstract][Full Text] [Related]
2. Influence of P-glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P-450 3A4.
Hochman JH; Chiba M; Nishime J; Yamazaki M; Lin JH
J Pharmacol Exp Ther; 2000 Jan; 292(1):310-8. PubMed ID: 10604964
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D Receptor-Mediated Upregulation of CYP3A4 and MDR1 by Quercetin in Caco-2 cells.
Chae YJ; Cho KH; Yoon IS; Noh CK; Lee HJ; Park Y; Ji E; Seo MD; Maeng HJ
Planta Med; 2016 Jan; 82(1-2):121-30. PubMed ID: 26366751
[TBL] [Abstract][Full Text] [Related]
4. Abiraterone inhibits 1α,25-dihydroxyvitamin D3 metabolism by CYP3A4 in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():50-8. PubMed ID: 24269662
[TBL] [Abstract][Full Text] [Related]
5. Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein.
Brimer C; Dalton JT; Zhu Z; Schuetz J; Yasuda K; Vanin E; Relling MV; Lu Y; Schuetz EG
Pharm Res; 2000 Jul; 17(7):803-10. PubMed ID: 10990198
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines.
Pfrunder A; Gutmann H; Beglinger C; Drewe J
J Pharm Pharmacol; 2003 Jan; 55(1):59-66. PubMed ID: 12625868
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1α,25-dihydroxyvitamin D3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells.
Maeng HJ; Chapy H; Zaman S; Pang KS
Eur J Pharm Sci; 2012 Jun; 46(3):149-66. PubMed ID: 22387228
[TBL] [Abstract][Full Text] [Related]
8. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
Patel J; Buddha B; Dey S; Pal D; Mitra AK
Am J Ther; 2004; 11(4):262-77. PubMed ID: 15266218
[TBL] [Abstract][Full Text] [Related]
9. CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies.
Engman HA; Lennernäs H; Taipalensuu J; Otter C; Leidvik B; Artursson P
J Pharm Sci; 2001 Nov; 90(11):1736-51. PubMed ID: 11745731
[TBL] [Abstract][Full Text] [Related]
10. Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells.
Fan J; Maeng HJ; Du Y; Kwan D; Pang KS
Eur J Pharm Sci; 2011 Jan; 42(1-2):19-29. PubMed ID: 20955791
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein potentiates CYP3A4-mediated drug disappearance during Caco-2 intestinal secretory detoxification.
Chan LM; Cooper AE; Dudley AL; Ford D; Hirst BH
J Drug Target; 2004; 12(7):405-13. PubMed ID: 15621665
[TBL] [Abstract][Full Text] [Related]
12. Role of c-Myc in nitric oxide-mediated suppression of cytochrome P450 3A4.
Watabe M; Isogai Y; Numazawa S; Yoshida T
Life Sci; 2003 Nov; 74(1):99-108. PubMed ID: 14575816
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 May; 141():94-103. PubMed ID: 24486455
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein-mediated efflux of indinavir metabolites in Caco-2 cells expressing cytochrome P450 3A4.
Hochman JH; Chiba M; Yamazaki M; Tang C; Lin JH
J Pharmacol Exp Ther; 2001 Jul; 298(1):323-30. PubMed ID: 11408558
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of nitric oxide on the induction of cytochrome P450 3A4 mRNA by 1,25-dihydroxyvitamin D3 in Caco-2 cells.
Hara H; Mitani N; Adachi T
Free Radic Res; 2000 Sep; 33(3):279-85. PubMed ID: 10993481
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug-metabolizing enzyme CYP3A4 in the human fetal intestine.
Theodoropoulos C; Demers C; Delvin E; Ménard D; Gascon-Barré M
Clin Endocrinol (Oxf); 2003 Apr; 58(4):489-99. PubMed ID: 12641633
[TBL] [Abstract][Full Text] [Related]
17. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
18. Gancao (Glycyrrhizae Radix) provides the main contribution to Shaoyao-Gancao decoction on enhancements of CYP3A4 and MDR1 expression via pregnane X receptor pathway in vitro.
Feng D; Tang T; Fan R; Luo J; Cui H; Wang Y; Gan P
BMC Complement Altern Med; 2018 Dec; 18(1):345. PubMed ID: 30594244
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D
Maeng HJ; Doan TNK; Yoon IS
Drug Dev Res; 2019 May; 80(3):333-342. PubMed ID: 30537097
[TBL] [Abstract][Full Text] [Related]
20. The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) in human intestinal cell lines, Caco-2 and LS180.
Aiba T; Susa M; Fukumori S; Hashimoto Y
Drug Metab Pharmacokinet; 2005 Aug; 20(4):268-74. PubMed ID: 16141606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]